Sinsin Pharmaceutical Co. Ltd (002800) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.70 Billion ≈ $3.18 Million USD) by net assets (₩71.01 Billion ≈ $48.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sinsin Pharmaceutical Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Sinsin Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sinsin Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sinsin Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NDL Ventures Limited NSE:NDLVENTURE	0.000x
Live Verdure Ltd AU:LV1	-0.448x
LightInTheBox Holding Co Ltd ARD NYSE:LITB	-1.560x
Toro Energy Ltd AU:TOE	-0.245x
ZENTEK LTD. F:ZAY0	-0.158x
Space Hellas SA AT:SPACE	-0.583x
Moberg Pharma AB (publ) ST:MOB	0.002x
Shalimar Paints Limited NSE:SHALPAINTS	-0.010x

Annual Cash Flow Conversion Efficiency for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Sinsin Pharmaceutical Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩65.87 Billion ≈ $44.64 Million	₩5.94 Billion ≈ $4.03 Million	0.090x	+42.55%
2023-12-31	₩62.09 Billion ≈ $42.08 Million	₩3.93 Billion ≈ $2.66 Million	0.063x	-30.80%
2022-12-31	₩59.70 Billion ≈ $40.46 Million	₩5.46 Billion ≈ $3.70 Million	0.091x	+21570.98%
2021-12-31	₩54.93 Billion ≈ $37.22 Million	₩23.18 Million ≈ $15.71K	0.000x	-98.73%
2020-12-31	₩56.20 Billion ≈ $38.08 Million	₩1.87 Billion ≈ $1.26 Million	0.033x	+141.52%
2019-12-31	₩56.36 Billion ≈ $38.20 Million	₩-4.51 Billion ≈ $-3.05 Million	-0.080x	-663.11%
2018-12-31	₩54.54 Billion ≈ $36.96 Million	₩774.24 Million ≈ $524.69K	0.014x	-83.80%
2017-12-31	₩52.12 Billion ≈ $35.32 Million	₩4.57 Billion ≈ $3.10 Million	0.088x	+8.00%
2016-12-31	₩34.43 Billion ≈ $23.33 Million	₩2.79 Billion ≈ $1.89 Million	0.081x	--

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$46.78 Million

₩69.03 Billion KRW

Market Cap Rank

#22219 Global

#1378 in Korea

Share Price

₩4550.00

Change (1 day)

-2.67%

52-Week Range

₩4350.00 - ₩6630.00

All Time High

₩13396.03